Status:
UNKNOWN
Remimazolam for Sedation in ICU Patients Undergoing Mechanical Ventilation
Lead Sponsor:
Tianjin Nankai Hospital
Conditions:
Sedation
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
Sedation is a component of the care of critically ill patients who are undergoing mechanical ventilation. Dexmedetomidine induces sedation while preserving a degree of arousability among patients in t...
Detailed Description
1. Title: Efficacy and Safety of Remimazolam for Sedation in ICU Patients Undergoing Mechanical Ventilation 2. Research center: Single Center 3. The Design of the study: Randomized, Controlled, Non-in...
Eligibility Criteria
Inclusion
- The main inclusion criteria are 18 years old or above, invasive mechanical ventilation is required, and the clinical need is mild to moderate Sedated (RASS score 0 to -3) patients.
Exclusion
- Refuse to participate in this study
- Patients with severe bradycardia (HR\<50 bpm)
- Patients who is pregnancy
- Patients with brain injury or neurosurgery
- Patients receiving sedation for treatment indications (such as epilepsy), not to tolerate a ventilator.
- Patients receiving any study medication within 30 days
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
488 Patients enrolled
Trial Details
Trial ID
NCT04815265
Start Date
April 1 2021
End Date
June 30 2024
Last Update
March 24 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.